Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,533 | 52,243 | 59,809 | 127,636 | 143,251 |
| Marketable Securities | 147,130 | 139,980 | 138,341 | 116,055 | 117,055 |
| Receivables | 22,198 | 24,467 | 25,158 | 22,987 | 21,235 |
| Other current assets | 5,383 | 4,503 | 7,333 | 5,147 | 5,528 |
| TOTAL | $236,244 | $221,193 | $230,641 | $271,825 | $287,069 |
| Non-Current Assets | |||||
| PPE Net | 38,788 | 41,198 | 42,790 | 44,451 | 45,895 |
| Investments And Advances | 5,088 | 35,736 | 35,491 | 5,262 | 7,521 |
| Intangibles | 535 | 845 | 1,153 | 242 | 1,116 |
| Other Non-Current Assets | 44,065 | 44,073 | 43,892 | 42,307 | 41,944 |
| TOTAL | $88,476 | $121,852 | $123,326 | $92,262 | $96,476 |
| Total Assets | $324,720 | $343,045 | $353,966 | $364,086 | $383,544 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,460 | 18,240 | 18,230 | 16,786 | 16,134 |
| Accounts payable and accrued liabilities | 17,277 | 16,095 | 17,522 | 17,209 | 18,664 |
| Other current liabilities | 13,511 | 11,902 | 10,824 | 7,408 | 10,925 |
| TOTAL | $145,752 | $148,577 | $167,432 | $162,569 | $166,269 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,013 | 63,399 | 55,856 | 51,037 | 50,882 |
| Deferred Revenues | 96,803 | 94,008 | 113,379 | 113,304 | 112,161 |
| Other Non-Current Liabilities | 29,054 | 30,591 | 33,567 | 34,277 | 35,360 |
| TOTAL | $103,067 | $93,990 | $89,423 | $85,314 | $86,242 |
| Total Liabilities | $248,819 | $242,567 | $256,855 | $247,883 | $252,511 |
| Shareholders' Equity | |||||
| Common Shares | 5,903 | 5,902 | 5,902 | 5,900 | 5,889 |
| Retained earnings | -334,131 | -307,861 | -308,455 | -347,691 | -329,607 |
| Other shareholders' equity | -33,316 | -32,725 | -33,885 | -37,271 | -39,537 |
| TOTAL | $75,901 | $100,478 | $97,111 | $116,204 | $131,033 |
| Total Liabilities And Equity | $324,720 | $343,045 | $353,966 | $364,087 | $383,544 |